Mdm2
برای مطالعهٔ بیشتر

Cahilly-Snyder L, Yang-Feng T, Francke U, George DL (May 1987). "Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line". Somatic Cell and Molecular Genetics. 13 (3): 235–44. doi:10.1007/BF01535205. PMID 3474784. S2CID 27300300.
Chen J, Lin J, Levine AJ (January 1995). "Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene". Molecular Medicine. 1 (2): 142–52. doi:10.1007/BF03401562. PMC 2229942. PMID 8529093.
Fang S, Jensen JP, Ludwig RL, Vousden KH, Weissman AM (March 2000). "Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53". The Journal of Biological Chemistry. 275 (12): 8945–51. doi:10.1074/jbc.275.12.8945. PMID 10722742. S2CID 25630836.
Freedman DA, Wu L, Levine AJ (January 1999). "Functions of the MDM2 oncoprotein". Cellular and Molecular Life Sciences. 55 (1): 96–107. doi:10.1007/s000180050273. PMID 10065155. S2CID 20034406.
Hay TJ, Meek DW (July 2000). "Multiple sites of in vivo phosphorylation in the MDM2 oncoprotein cluster within two important functional domains". FEBS Letters. 478 (1–2): 183–6. doi:10.1016/S0014-5793(00)01850-0. PMID 10922493. S2CID 40688636.
Honda R, Tanaka H, Yasuda H (December 1997). "Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53". FEBS Letters. 420 (1): 25–7. doi:10.1016/S0014-5793(97)01480-4. PMID 9450543. S2CID 29014813.
Honda R, Yasuda H (March 2000). "Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase". Oncogene. 19 (11): 1473–6. doi:10.1038/sj.onc.1203464. PMID 10723139. S2CID 8734229.
Kubbutat MH, Jones SN, Vousden KH (May 1997). "Regulation of p53 stability by Mdm2". Nature. 387 (6630): 299–303. Bibcode:1997Natur.387..299K. doi:10.1038/387299a0. PMID 9153396. S2CID 4329670.
Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine AJ, Pavletich NP (November 1996). "Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain". Science. 274 (5289): 948–53. Bibcode:1996Sci...274..948K. doi:10.1126/science.274.5289.948. PMID 8875929. S2CID 33081920.
Meek DW, Knippschild U (December 2003). "Posttranslational modification of MDM2". Molecular Cancer Research. 1 (14): 1017–26. PMID 14707285.
Midgley CA, Desterro JM, Saville MK, Howard S, Sparks A, Hay RT, Lane DP (May 2000). "An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo". Oncogene. 19 (19): 2312–23. doi:10.1038/sj.onc.1203593. PMID 10822382. S2CID 24814361.
Momand J, Wu HH, Dasgupta G (January 2000). "MDM2--master regulator of the p53 tumor suppressor protein". Gene. 242 (1–2): 15–29. doi:10.1016/S0378-1119(99)00487-4. PMID 10721693.
Momand J, Zambetti GP, Olson DC, George D, Levine AJ (June 1992). "The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation". Cell. 69 (7): 1237–45. doi:10.1016/0092-8674(92)90644-R. PMID 1535557. S2CID 22594319.
Shieh SY, Ikeda M, Taya Y, Prives C (October 1997). "DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2". Cell. 91 (3): 325–34. doi:10.1016/S0092-8674(00)80416-X. PMID 9363941. S2CID 11328296.
Tao W, Levine AJ (June 1999). "P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2". Proceedings of the National Academy of Sciences of the United States of America. 96 (12): 6937–41. Bibcode:1999PNAS...96.6937T. doi:10.1073/pnas.96.12.6937. PMC 22020. PMID 10359817.
Tao W, Levine AJ (March 1999). "Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53". Proceedings of the National Academy of Sciences of the United States of America. 96 (6): 3077–80. Bibcode:1999PNAS...96.3077T. doi:10.1073/pnas.96.6.3077. PMC 15897. PMID 10077639.